| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1224145
[patent_doc_number] => 06699869
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-02
[patent_title] => '-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins'
[patent_app_type] => B1
[patent_app_number] => 09/561107
[patent_app_country] => US
[patent_app_date] => 2000-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 24405
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/699/06699869.pdf
[firstpage_image] =>[orig_patent_app_number] => 09561107
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/561107 | -sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins | Apr 27, 2000 | Issued |
| 09/530298 | Affinity markers for human serum albumin | Apr 26, 2000 | Abandoned |
Array
(
[id] => 1025163
[patent_doc_number] => 06884868
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-04-26
[patent_title] => 'Cyclic hexapeptides having antibiotic activity'
[patent_app_type] => utility
[patent_app_number] => 09/926385
[patent_app_country] => US
[patent_app_date] => 2000-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84941
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/884/06884868.pdf
[firstpage_image] =>[orig_patent_app_number] => 09926385
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/926385 | Cyclic hexapeptides having antibiotic activity | Apr 24, 2000 | Issued |
| 09/529960 | SPACER PEPTIDES AND MEMBRANES CONTAINING SAME | Apr 23, 2000 | Abandoned |
Array
(
[id] => 1312730
[patent_doc_number] => 06613879
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-02
[patent_title] => 'FAP-activated anti-tumour compounds'
[patent_app_type] => B1
[patent_app_number] => 09/553800
[patent_app_country] => US
[patent_app_date] => 2000-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13252
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 280
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/613/06613879.pdf
[firstpage_image] =>[orig_patent_app_number] => 09553800
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/553800 | FAP-activated anti-tumour compounds | Apr 20, 2000 | Issued |
Array
(
[id] => 7643752
[patent_doc_number] => 06429288
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-06
[patent_title] => 'Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds'
[patent_app_type] => B1
[patent_app_number] => 09/486679
[patent_app_country] => US
[patent_app_date] => 2000-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13991
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/429/06429288.pdf
[firstpage_image] =>[orig_patent_app_number] => 09486679
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/486679 | Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds | Mar 30, 2000 | Issued |
Array
(
[id] => 1241232
[patent_doc_number] => 06683055
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-27
[patent_title] => 'Low molecular weight inhibitors of complement proteases'
[patent_app_type] => B1
[patent_app_number] => 09/539811
[patent_app_country] => US
[patent_app_date] => 2000-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48839
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 722
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/683/06683055.pdf
[firstpage_image] =>[orig_patent_app_number] => 09539811
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/539811 | Low molecular weight inhibitors of complement proteases | Mar 29, 2000 | Issued |
Array
(
[id] => 1312705
[patent_doc_number] => 06613874
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-02
[patent_title] => 'Melanocortin receptor ligands'
[patent_app_type] => B1
[patent_app_number] => 09/537789
[patent_app_country] => US
[patent_app_date] => 2000-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 16498
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/613/06613874.pdf
[firstpage_image] =>[orig_patent_app_number] => 09537789
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/537789 | Melanocortin receptor ligands | Mar 28, 2000 | Issued |
Array
(
[id] => 475700
[patent_doc_number] => 07226991
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-06-05
[patent_title] => 'Phenylalanine derivatives'
[patent_app_type] => utility
[patent_app_number] => 09/937150
[patent_app_country] => US
[patent_app_date] => 2000-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 22
[patent_no_of_words] => 15951
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/226/07226991.pdf
[firstpage_image] =>[orig_patent_app_number] => 09937150
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/937150 | Phenylalanine derivatives | Mar 22, 2000 | Issued |
Array
(
[id] => 1392520
[patent_doc_number] => 06531157
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-11
[patent_title] => 'Stable emulsions and dry powders of mixtures of fat-soluble vitamins, their preparations and use'
[patent_app_type] => B1
[patent_app_number] => 09/531816
[patent_app_country] => US
[patent_app_date] => 2000-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4308
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/531/06531157.pdf
[firstpage_image] =>[orig_patent_app_number] => 09531816
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/531816 | Stable emulsions and dry powders of mixtures of fat-soluble vitamins, their preparations and use | Mar 20, 2000 | Issued |
Array
(
[id] => 1240635
[patent_doc_number] => 06686445
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-02-03
[patent_title] => 'Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same'
[patent_app_type] => B1
[patent_app_number] => 09/509066
[patent_app_country] => US
[patent_app_date] => 2000-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10410
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/686/06686445.pdf
[firstpage_image] =>[orig_patent_app_number] => 09509066
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/509066 | Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same | Mar 20, 2000 | Issued |
Array
(
[id] => 1292460
[patent_doc_number] => 06630570
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-07
[patent_title] => 'Short-chain peptide-dye conjugates as contrast media for optical diagnosis'
[patent_app_type] => B1
[patent_app_number] => 09/528200
[patent_app_country] => US
[patent_app_date] => 2000-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 23546
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 390
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/630/06630570.pdf
[firstpage_image] =>[orig_patent_app_number] => 09528200
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/528200 | Short-chain peptide-dye conjugates as contrast media for optical diagnosis | Mar 16, 2000 | Issued |
Array
(
[id] => 1533704
[patent_doc_number] => 06410685
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-25
[patent_title] => 'Antistress agents and functional foods'
[patent_app_type] => B1
[patent_app_number] => 09/508777
[patent_app_country] => US
[patent_app_date] => 2000-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5210
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/410/06410685.pdf
[firstpage_image] =>[orig_patent_app_number] => 09508777
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/508777 | Antistress agents and functional foods | Mar 14, 2000 | Issued |
Array
(
[id] => 1596978
[patent_doc_number] => 06492489
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-10
[patent_title] => 'Synthetic hypusine peptides'
[patent_app_type] => B1
[patent_app_number] => 09/519693
[patent_app_country] => US
[patent_app_date] => 2000-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9317
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/492/06492489.pdf
[firstpage_image] =>[orig_patent_app_number] => 09519693
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/519693 | Synthetic hypusine peptides | Mar 6, 2000 | Issued |
Array
(
[id] => 1596986
[patent_doc_number] => 06492491
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-10
[patent_title] => 'Method of making hypusine peptides'
[patent_app_type] => B1
[patent_app_number] => 09/519209
[patent_app_country] => US
[patent_app_date] => 2000-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9527
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/492/06492491.pdf
[firstpage_image] =>[orig_patent_app_number] => 09519209
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/519209 | Method of making hypusine peptides | Mar 5, 2000 | Issued |
Array
(
[id] => 1062914
[patent_doc_number] => 06849605
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-02-01
[patent_title] => 'Inhibitors of serine protease activity, methods and compositions for treatment of viral infections'
[patent_app_type] => utility
[patent_app_number] => 09/518098
[patent_app_country] => US
[patent_app_date] => 2000-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 17107
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 2006
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/849/06849605.pdf
[firstpage_image] =>[orig_patent_app_number] => 09518098
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/518098 | Inhibitors of serine protease activity, methods and compositions for treatment of viral infections | Mar 2, 2000 | Issued |
Array
(
[id] => 1126898
[patent_doc_number] => 06790834
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-14
[patent_title] => 'Cytostatic agents'
[patent_app_type] => B1
[patent_app_number] => 09/514083
[patent_app_country] => US
[patent_app_date] => 2000-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22934
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/790/06790834.pdf
[firstpage_image] =>[orig_patent_app_number] => 09514083
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/514083 | Cytostatic agents | Feb 27, 2000 | Issued |
Array
(
[id] => 1213242
[patent_doc_number] => 06710086
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-23
[patent_title] => 'Protected forms of pharmacologically active agents and uses therefor'
[patent_app_type] => B1
[patent_app_number] => 09/515043
[patent_app_country] => US
[patent_app_date] => 2000-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18187
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/710/06710086.pdf
[firstpage_image] =>[orig_patent_app_number] => 09515043
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/515043 | Protected forms of pharmacologically active agents and uses therefor | Feb 24, 2000 | Issued |
| 09/423578 | SOMATOSTATIN AND SOMATOSTATIN AGONISTS FOR TREATING INSULIN INSENSITIVITY AND SYNDROME X | Feb 22, 2000 | Abandoned |
| 09/486019 | Growth hormone secretagogues | Feb 17, 2000 | Abandoned |
